Injection medications typically produce faster absorption and more predictable blood levels than oral formulations, potentially explaining their lower starting costs at PlexusDx
Retatrutide cannot be marketed for human use unless it has gone through the MHRAs approval process , which includes safety and efficacy trials
Whats new is actively prescribing medications whose primary indication is metabolic (obesity, diabetes) but that also have psychiatric effects
The mean age of participants was 55 years, and the mean duration of diabetes was 9 years
The latest data also shows that most people stop taking GLP-1s within 12 months and experience significant side effects throughout treatment
Participants receiving the highest doses saw significant weight loss, with some shedding nearly a third of their body weight, outcomes comparable to bariatric surgery